Ruifeng Shi

738 total citations
46 papers, 493 citations indexed

About

Ruifeng Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ruifeng Shi has authored 46 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Ruifeng Shi's work include Lung Cancer Treatments and Mutations (11 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (9 papers). Ruifeng Shi is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (9 papers). Ruifeng Shi collaborates with scholars based in China, United States and Sweden. Ruifeng Shi's co-authors include Jun Chen, Li Y, Zihe Zhang, M. Liu, Hongbing Zhang, Guangsheng Zhu, Hongyu Liu, Hongyu Liu, Zhenhua Pan and Renliang Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ruifeng Shi

42 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruifeng Shi China 14 233 130 105 100 74 46 493
Yi He China 14 223 1.0× 176 1.4× 143 1.4× 69 0.7× 69 0.9× 60 542
Youbin Cui China 13 249 1.1× 88 0.7× 181 1.7× 85 0.8× 77 1.0× 38 562
Jiaxin Liu China 11 286 1.2× 76 0.6× 154 1.5× 94 0.9× 62 0.8× 49 498
Yu‐Tian Xiao China 12 245 1.1× 186 1.4× 141 1.3× 90 0.9× 22 0.3× 25 724
Dawei Zheng China 13 462 2.0× 99 0.8× 225 2.1× 53 0.5× 50 0.7× 30 620
Guoqiang Bao China 12 147 0.6× 61 0.5× 50 0.5× 74 0.7× 52 0.7× 35 437
Tomoko Uchiyama Japan 17 126 0.5× 131 1.0× 119 1.1× 111 1.1× 64 0.9× 68 684

Countries citing papers authored by Ruifeng Shi

Since Specialization
Citations

This map shows the geographic impact of Ruifeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Shi more than expected).

Fields of papers citing papers by Ruifeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Shi. The network helps show where Ruifeng Shi may publish in the future.

Co-authorship network of co-authors of Ruifeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Shi. A scholar is included among the top collaborators of Ruifeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Shi. Ruifeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shi, Ruifeng, Hongbing Zhang, Zihe Zhang, et al.. (2025). Unravelling the prognostic and operative role of intratumoural microbiota in non‐small cell lung cancer: Insights from 16S rRNA and RNA sequencing. Clinical and Translational Medicine. 15(1). e70156–e70156. 5 indexed citations
3.
Shi, Ruifeng, Yikai Dou, Manyu Luo, et al.. (2025). Alterations in resting-state brain activity patterns following antidepressant treatment: insights from a coordinate-based meta-analysis. Psychological Medicine. 55. e380–e380.
4.
5.
Zhang, Zihe, Li Y, Ruifeng Shi, et al.. (2024). L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma. Cell Death and Disease. 15(9). 649–649. 1 indexed citations
6.
Shi, Ruifeng, Jing Cen, Gunilla T. Westermark, et al.. (2023). CLEC11A improves insulin secretion and promotes cell proliferation in human beta-cells. Journal of Molecular Endocrinology. 71(1). 1 indexed citations
7.
Huang, Hua, Guangsheng Zhu, Ruifeng Shi, et al.. (2022). Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma. Journal of Cancer. 13(8). 2631–2643. 3 indexed citations
8.
Y, Li, Ruifeng Shi, Yuan Yin, et al.. (2022). Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer. Frontiers in Chemistry. 10. 837987–837987. 14 indexed citations
9.
Huang, Hua, Zijian Shi, Li Y, et al.. (2022). Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis. Frontiers in Oncology. 12. 850943–850943. 9 indexed citations
10.
Zhu, Guangsheng, Hua Huang, Ruifeng Shi, et al.. (2021). Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma. Thoracic Cancer. 12(12). 1890–1899. 15 indexed citations
11.
Li, Ying, Li Y, Hongbing Zhang, et al.. (2021). EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation. BMC Pulmonary Medicine. 21(1). 190–190. 13 indexed citations
12.
Li, Weiting, Li Y, Hongbing Zhang, et al.. (2021). HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. Journal of Cancer. 12(18). 5562–5572. 29 indexed citations
13.
Shi, Ruifeng, Juan Hu, Wei Li, et al.. (2019). Protective effects of Clec11a in islets against lipotoxicity via modulation of proliferation and lipid metabolism in mice. Experimental Cell Research. 384(1). 111613–111613. 8 indexed citations
14.
Shi, Zhang, Xuan Zheng, Ruifeng Shi, et al.. (2018). Score for lung adenocarcinoma in China with EGFR mutation of exon 19. Medicine. 97(38). e12537–e12537. 3 indexed citations
15.
Shi, Zhang, Xuan Zheng, Ruifeng Shi, et al.. (2017). Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma. Scientific Reports. 7(1). 364–364. 24 indexed citations
16.
Cao, Qinqin, Pei Pei, Jun Zhang, et al.. (2016). Hypertension unawareness among Chinese patients with first-ever stroke. BMC Public Health. 16(1). 170–170. 12 indexed citations
17.
Zhao, Lingling, Qiliang Dai, Xiangliang Chen, et al.. (2016). Neutrophil-to-Lymphocyte Ratio Predicts Length of Stay and Acute Hospital Cost in Patients with Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 25(4). 739–744. 32 indexed citations
18.
Liu, Hengwei, Ruifeng Shi, Xingfen Wang, et al.. (2013). Characterization and Expression Analysis of a Fiber Differentially Expressed Fasciclin-like Arabinogalactan Protein Gene in Sea Island Cotton Fibers. PLoS ONE. 8(7). e70185–e70185. 15 indexed citations
19.
Shi, Ruifeng, et al.. (2012). Cloning of a phosphatidylinositol 4-kinase gene based on fiber strength transcriptome QTL mapping in the cotton species Gossypium barbadense. Genetics and Molecular Research. 11(3). 3367–3378. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi He Breakdown of academic impact, for papers by Youbin Cui Breakdown of academic impact, for papers by Jiaxin Liu Breakdown of academic impact, for papers by Yu‐Tian Xiao Breakdown of academic impact, for papers by Dawei Zheng Breakdown of academic impact, for papers by Guoqiang Bao Breakdown of academic impact, for papers by Tomoko Uchiyama
Rankless by CCL
2026